# Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes

> **NCT06273891** · PHASE3 · RECRUITING · sponsor: **Inova Health Care Services** · enrollment: 140 (estimated)

## Conditions studied

- Premature Rupture of Membrane

## Interventions

- **DRUG:** Erythromycin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT06273891
- **Lead sponsor:** Inova Health Care Services
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-08
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-10-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273891, "Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06273891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*